Of particular note, treatment of NK-92 and NKD cells with MVs of hypoxic tumor cells dramatically decreased surface NKG2D expression, which was abolished by anti-TGF-b blocking antibody [37]. This evidence concerns the gene TGFB1 and neoplasm.